Lista de obras - James P Morden - Dominio Público Uruguay

A poetic story: lessons learnt from the world's largest breast cancer window of opportunity study.

artículo científico publicado en 2015

Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, c ⬇️

article

Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial

scientific article published on April 2016

Adjusting Survival Time Estimates to Account for Treatment Switching in Randomized Controlled Trials—an Economic Evaluation Context

article

Adjuvant Hormone Therapy May Improve Survival in Epithelial Ovarian Cancer: Results of the AHT Randomized Trial.

artículo científico publicado en 2015

Analysis techniques in the presence of non-proportional hazards (PH); application to an ovarian cancer RCT with long-term follow-up.

artículo científico publicado en 2015

Assessing methods for dealing with treatment switching in clinical trials: A follow-up simulation study.

artículo científico publicado en 2016

Assessing methods for dealing with treatment switching in randomised controlled trials: a simulation study ⬇️

artículo científico publicado el 11 de enero de 2011

Benefits and challenges of electronic data capture (EDC) systems versus paper case report forms.

artículo científico publicado en 2015

Bone marrow micrometastases in early breast cancer-30-year outcome

artículo científico publicado en 2016

Carpal tunnel syndrome and musculoskeletal symptoms in postmenopausal women with early breast cancer treated with exemestane or tamoxifen after 2-3 years of tamoxifen: a retrospective analysis of the Intergroup Exemestane Study

artículo científico publicado en 2012

Current attitudes of head and neck oncologists in the United Kingdom to induction chemotherapy for locally advanced head and neck cancer: A survey of centres participating in a national randomised controlled trial

artículo científico publicado en 2013

DARS: a phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancer

artículo científico publicado en 2016

Design considerations when transitioning from paper case report forms (CRFS) to electronic data capture (EDC).

artículo científico publicado en 2015

Disease-related outcomes with long-term follow-up: an updated analysis of the intergroup exemestane study

artículo científico publicado en 2011

Dosimetric explanations of fatigue in head and neck radiotherapy: an analysis from the PARSPORT Phase III trial.

artículo científico publicado en 2012

Fatigue during chemoradiotherapy for nasopharyngeal cancer and its relationship to radiation dose distribution in the brain.

artículo científico publicado en 2013

First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015).

artículo científico publicado en 2011

Heterogeneity in global gene expression profiles between biopsy specimens taken peri-surgically from primary ER-positive breast carcinomas

artículo científico publicado en 2016

Immunogenicity of pandemic (H1N1) 2009 vaccine in children with cancer in the United Kingdom

artículo científico publicado en 2010

Impact of mutational profiles on response of primary oestrogen receptor-positive breast cancers to oestrogen deprivation

artículo científico publicado en 2016

Long-Term Follow-Up of the Intergroup Exemestane Study ⬇️

artículo científico publicado en 2017

Managing non-proportionality of hazards (PH) within TNT: a randomised phase III trial of carboplatin compared to docetaxel for patients with metastatic or recurrent locally advanced triple negative (TN) or brca1/2 breast cancer (BC).

artículo científico publicado en 2015

NEOCENT: a randomised feasibility and translational study comparing neoadjuvant endocrine therapy with chemotherapy in ER-rich postmenopausal primary breast cancer

artículo científico publicado en 2014

Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial

artículo científico publicado en 2011

Recovery of Salivary Function: Contralateral Parotid-sparing Intensity-modulated Radiotherapy versus Bilateral Superficial Lobe Parotid-sparing Intensity-modulated Radiotherapy

artículo científico publicado en 2016

Reply to S. Kilickap et al, Y. Karakas et al, and I.A. Voutsadakis

artículo científico publicado en 2016

Lista de obras de James P Morden

A poetic story: lessons learnt from the world's largest breast cancer window of opportunity study.

Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, c ⬇️

Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial

Adjusting Survival Time Estimates to Account for Treatment Switching in Randomized Controlled Trials—an Economic Evaluation Context

Adjuvant Hormone Therapy May Improve Survival in Epithelial Ovarian Cancer: Results of the AHT Randomized Trial.

Analysis techniques in the presence of non-proportional hazards (PH); application to an ovarian cancer RCT with long-term follow-up.

Assessing methods for dealing with treatment switching in clinical trials: A follow-up simulation study.

Assessing methods for dealing with treatment switching in randomised controlled trials: a simulation study ⬇️

Benefits and challenges of electronic data capture (EDC) systems versus paper case report forms.

Bone marrow micrometastases in early breast cancer-30-year outcome

Carpal tunnel syndrome and musculoskeletal symptoms in postmenopausal women with early breast cancer treated with exemestane or tamoxifen after 2-3 years of tamoxifen: a retrospective analysis of the Intergroup Exemestane Study

Current attitudes of head and neck oncologists in the United Kingdom to induction chemotherapy for locally advanced head and neck cancer: A survey of centres participating in a national randomised controlled trial

DARS: a phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancer

Design considerations when transitioning from paper case report forms (CRFS) to electronic data capture (EDC).

Disease-related outcomes with long-term follow-up: an updated analysis of the intergroup exemestane study

Dosimetric explanations of fatigue in head and neck radiotherapy: an analysis from the PARSPORT Phase III trial.

Fatigue during chemoradiotherapy for nasopharyngeal cancer and its relationship to radiation dose distribution in the brain.

First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015).

Heterogeneity in global gene expression profiles between biopsy specimens taken peri-surgically from primary ER-positive breast carcinomas

Immunogenicity of pandemic (H1N1) 2009 vaccine in children with cancer in the United Kingdom

Impact of mutational profiles on response of primary oestrogen receptor-positive breast cancers to oestrogen deprivation

Long-Term Follow-Up of the Intergroup Exemestane Study ⬇️

Managing non-proportionality of hazards (PH) within TNT: a randomised phase III trial of carboplatin compared to docetaxel for patients with metastatic or recurrent locally advanced triple negative (TN) or brca1/2 breast cancer (BC).

NEOCENT: a randomised feasibility and translational study comparing neoadjuvant endocrine therapy with chemotherapy in ER-rich postmenopausal primary breast cancer

Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial

Recovery of Salivary Function: Contralateral Parotid-sparing Intensity-modulated Radiotherapy versus Bilateral Superficial Lobe Parotid-sparing Intensity-modulated Radiotherapy

Reply to S. Kilickap et al, Y. Karakas et al, and I.A. Voutsadakis